731
Views
12
CrossRef citations to date
0
Altmetric
Review Article

The patients’ view: age-related macular degeneration and its effects – a meta-synthesis

ORCID Icon & ORCID Icon
Pages 661-671 | Received 05 Jul 2019, Accepted 26 May 2020, Published online: 23 Jun 2020

References

  • Vos T, Allen C, Arora M, ET AL. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–1602.
  • Resnikoff S, Pascolini D, Etya’ale D, ET AL. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844–851.
  • Wong WL, Su X, Li X, ET AL. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health. 2014;2(2):e106–e116.
  • Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. 2008;358(24):2606–2617.
  • de Jong EK, Geerlings MJ, den Hollander AI. Age-related macular degeneration. In: Xiaoyi Raymond Gao, editor. Genetics and genomics of eye disease. Cambridge (MA): Academic Press; 2020. p. 155–180.
  • Boyle J, Vukicevic M, Koklanis K, ET AL. Experiences of patients undergoing repeated intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Psychol Health Med. 2018;23(2):127–140.
  • Heimes B, Gunnemann F, Ziegler M, ET AL. Compliance von Patienten mit altersabhängiger Makuladegeneration unter Anti-VEGF-Therapie. Ophthalmologe. 2016;113(11):925–932.
  • Finger R. [Blindness in Germany: dimensions and perspectives]. Ophthalmologe. 2007;104(10):839–844.
  • Horowitz A, Reinhardt JP, Kennedy GJ. Major and subthreshold depression among older adults seeking vision rehabilitation services. Am J Geriatr Psychiatry. 2005;13(3):180–187.
  • Brown GC, Brown MM, Sharma S, ET AL. The burden of age-related macular degeneration: a value-based medicine analysis. Trans Am Ophthalmol Soc. 2005;103:173–184, discussion 84–6.
  • Lam N, Leat SJ. Barriers to accessing low-vision care: the patient’s perspective. Can J Ophthalmol. 2013;48(6):458–462.
  • van der Aa HP, Hoeben M, Rainey L, ET AL. Why visually impaired older adults often do not receive mental health services: the patient’s perspective. Qual Life Res. 2015;24(4):969–978.
  • Bennion AE, Shaw RL, Gibson JM. What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research. Soc Sci Med. 2012;75(6):976–985.
  • Finfgeld D. Metasynthesis: the state of the art-so far. Qual Health Res. 2003;13(7):893–904.
  • CASP. Critical Appraisal Programme (CASP) Qualitative Research Checklist 2018. Available from: https://casp-uk.net/wp-content/uploads/2018/01/CASP-Qualitative-Checklist-2018.pdf
  • Noyes J, Popay J, Pearson A, ET AL. Qualitative research and cochrane reviews. In: Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions (pp. 571–591). Chichester (UK): John Wiley & Sons; 2008.
  • Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis. London (UK): Sage; 2006.
  • McCloud C, Khadka J, Gilhotra JS, ET AL. Divergence in the lived experience of people with macular degeneration. Optom Vis Sci. 2014;91(8):966–974.
  • McCloud C, Lake S. Understanding the patient’s lived experience of neovascular age-related macular degeneration: a qualitative study. Eye (Lond). 2015;29(12):1561–1569.
  • Cimarolli VR, Boerner K, Brennan-Ing M, ET AL. Challenges faced by older adults with vision loss: a qualitative study with implications for rehabilitation. Clin Rehabil. 2012;26(8):748–757.
  • Burton AE, Shaw RL, Gibson JM. ‘I’d like to know what causes it, you know, anything I’ve done?’ Are we meeting the information and support needs of patients with macular degeneration? A qualitative study. BMJ Open. 2013;3(11):e003306.
  • Burton AE, Shaw R, Gibson J. Experiences of patients with age-related macular degeneration receiving anti-vascular endothelial growth factor therapy: a qualitative study. Br J Visual Impairment. 2013;31(3):178–188.
  • Burton AE, Shaw RL, Gibson JM. Living together with age-related macular degeneration: an interpretative phenomenological analysis of sense-making within a dyadic relationship. J Health Psychol. 2015;20(10):1285–1295.
  • Moore LW, Constantino RE, Allen M. Severe visual impairment in older women. West J Nurs Res. 2000;22(5):571–595.
  • Moore LW, Miller M. Older men’s experiences of living with severe visual impairment. J Adv Nurs. 2003;43(1):10–18.
  • Stanford P, Waterman H, Russell WB, ET AL. Psychosocial adjustment in age related macular degeneration. Br J Vis Impairment. 2009;27(2):129–146.
  • Wong EYH, Guymer RH, Hassell JB, ET AL. The experience of age-related macular degeneration. J Vis Impairment Blindness. 2004;98(10):629–640.
  • Feely M, Vetere A, Myers L. A qualitative analysis of reading rehabilitation of persons with age-related macular degeneration. J Visual Impairment Blindness. 2007;101(1):44–49.
  • Thetford C, Hodge S, Harding S, ET AL. Living with age-related macular degeneration treatment: Patient experiences of being treated with ranibizumab (Lucentis)(R) intravitreal injections. Br J Visual Impairment. 2013;31(2):89–101.
  • Mogk M. The difference that age makes: cultural factors that shape older adults’ responses to age-related macular degeneration. J Vis Impairment Blindness. 2008;102(10):581–590.
  • Mayer H. Aus einem anderen Blickwinkel betrachten: der Umgang mit chronischer altersassoziierter Erkrankung am Beispiel der altersbedingten Makuladegeneration. Journal für qualitative Forschung in Pflege und Gesundheitswissenschaft. 2015;2(2):146–155.
  • Bian W, Wan J, Smith G, ET AL. Domains of health-related quality of life in age-related macular degeneration: a qualitative study in the Chinese cultural context. BMJ Open. 2018;8(4):e018756.
  • Owsley C, McGwin G, Scilley Jr K, ET AL. Focus groups with persons who have age-related macular degeneration: emotional issues. Rehabil Psychol. 2006;51(1):23–29.
  • Husler S, Schmid H. [Coping with wet age-related macular degeneration-a study from Switzerland]. Klin Monbl Augenheilkd. 2013;230(12):1251–1256.
  • Porter EJ. Home care as a complex experience: a chronological case study. Home Health Care Serv Q. 2008;27(3):167–186.
  • Smith TM. Adaptation to low vision caused by age-related macular degeneration: a case study. J Vis Impairment Blindness. 2008;102(11):725–730.
  • Emsfors Å, Christensson L, Elgán C. Nursing actions that create a sense of good nursing care in patients with wet age-related macular degeneration. J Clin Nurs. 2017;26(17–18):2680–2688.
  • Ivanoff SD, Sjöstrand J, Klepp K, ET AL. Planning a health education programme for the elderly visually impaired person-a focus group study. Disabil Rehabil. 1996;18(10):515–522.
  • Sivaprasad S, Tschosik EA, Guymer RH, ET AL. Living with geographic atrophy: an ethnographic study. Ophthalmol Ther. 2019;8(1):115–124.
  • Lane J, Rohan EMF, Sabeti F, ET AL. Impacts of impaired face perception on social interactions and quality of life in age-related macular degeneration: a qualitative study and new community resources. PloS One. 2018;13(12):e0209218.
  • Cimarolli VR, Boerner K. Blindness. Social support and well-being in adults who are visually impaired. J Vis Impairment Blindness. 2005;99(9):521–534.
  • Prenner JL, Halperin LS, Rycroft C, ET AL. Disease burden in the treatment of age-related macular degeneration: findings from a time-and-motion study. Am J Ophthalmol. 2015;160(4):725–731.e1.
  • Harrer M. Krankheitsverarbeitung (Coping). In: Frischenschlager O, Hexel M, Kantner-Rumplmair W, ET AL, editors. Lehrbuch der Psychosozialen Medizin. Wein: Springer; 1995. p. 409–426.
  • Schilling OK, Wahl H-W. Modeling late-life adaptation in affective well-being under a severe chronic health condition: the case of age-related macular degeneration. Psychol Aging. 2006;21(4):703–714.
  • Wahl H-W, Heyl V, Langer N. [Quality of life by limited vision in old age: the example of age-related macula degeneration]. Ophthalmologe. 2008;105(8):735–743.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.